Sector Research at JonesTrading
Jones’ Equity Research Group provides quantitative and qualitative insights to equip clients with the critical information they need to make sound, informed choices in the market. Through fundamental analysis and forward-looking perspectives, we help investors navigate complex financial landscapes with confidence.
Hans Vitzthum
Director of Research
Mr. Vitzhum has over 30 years of experience in institutional sales, research management, equity capital markets, and investor relations. Throughout his career, he has overseen more than 100 healthcare IPOs and follow-on offerings. In 2024, Hans joined JonesTrading, taking on the role of overseeing business development with a focus on building momentum to drive greater value for clients and partners. Prior to this, he served as a Managing Director/Partner at LifeSci Partners and as Managing Directory at Lazard Capital Markets.
Soumit Roy PhD
Managing Director, Healthcare
Soumit Roy, PhD covers Biotechnology companies within the Healthcare sector. Soumit’s focus is on disruptive technology with specialization in oncology, notably T cell therapy, targeted medicines, and next generation immuno-oncology. Before joining JonesTrading, Dr. Roy was a Senior Research Associate at SunTrust Robinson Humphrey, covering small- and mid-cap biotechnology companies. He was a post-doctoral fellow in the Clinical Immunology Department at the Icahn School of Medicine at Mount Sinai, New York. He earned his PhD from the Albert Einstein College of Medicine, New York. He holds Master’s degrees in Developmental Biology and Biochemistry, and has published in the highest rated scientific journals.
Biotechnology Sector
Rare Disease and I&I
Catherine Novack
Director, Healthcare
Catherine Novack covers biotechnology companies within the Healthcare sector. Before joining JonesTrading, Ms. Novack worked as a research associate covering biotechnology and healthcare at Canaccord Genuity and National Securities.
Biotechnology Sector
CNS, Commercial Medicine & Radiopharma
Justin Walsh PhD
Director, Healthcare
Justin Walsh PhD covers biotechnology companies within the Healthcare sector. Before joining JonesTrading, Dr. Walsh was a Research Analyst at B. Riley Securities covering SMID cap biotechnology and healthcare companies with a primary focus on oncology.
Biotechnology Sector
I&I, Ophthalmology, Pulmonology, Metabolic and Fibrotic Diseases
Debanjana Chatterjee PhD
Vice President, Healthcare
Debanjana Chatterjee, PhD, is a Senior Analyst on our Healthcare Research team. Prior to joining Jones, she served as AVP, Senior Associate at Citi, where she specialized in the small- and mid-cap biotechnology sector.
Financial Services Sector
Specialty Finance & Real Estate
Jason Weaver
Managing Director, Equity Research
Jason Weaver is Managing Director, Equity Research with a focus on Specialty Finance and Real Estate. Mr. Weaver has 20 years of investment experience and 13 years in equity research, covering the specialty/mortgage finance and real estate sectors at firms including Sterne Agee, Wedbush, and Compass Point.
Financial Services Sector
Specialty Finance & Real Estate
Matthew Erdner
Research Associate
Matthew Erdner covers Specialty Finance and Real Estate companies within the Financial Services Sector. Before joining JonesTrading, Matthew worked as a Data Engineer at Interloop.ai, specializing in data visualization and data migration. He has a BS in Data Science with an emphasis in Business Intelligence from The College of Charleston.
Technology Sector
Data Centers, Bitcoin Mining & Emerging Technologies
Stephen Glagola
Director, Technology
Stephen has 13 years of equity research experience, with over a decade focusing TMT. He was most recently on the TMT equity research team at TD Cowen as a senior analyst covering live event, leisure, gaming, and crypto stocks.
Contact Us
Sector Research
212.267.0777 – phone
